Position in OGN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$270
+$151 QoQ
Shares Held
20
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#556
of 626 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Steigerwald, Gordon & Koch Inc. holds $72,202,828 across 15 Drug Manufacturers - General names. OGN ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
113,876 | $28,921,087 | |
| 2 | AMGN |
Amgen Inc
|
70,256 | $25,441,102 | |
| 3 | PFE |
Pfizer Inc
|
502,925 | $12,110,434 | |
| 4 | LLY |
ELI LILLY & Co
|
2,796 | $3,353,606 | |
| 5 | ABBV |
AbbVie Inc.
|
3,270 | $822,862 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,655 | $598,167 | |
| 7 | NVS |
Novartis AG
|
2,091 | $327,701 | |
| 8 | AZN |
Astrazeneca PLC
|
1,120 | $212,374 |
All Filings in OGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $270 | 20 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $119 | 20 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $143 | 20 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $213 | 20 | Shares | Sole | 2025-10-23 | |
| No filing history on record for this holder in this stock. | ||||||